The founder of Lessonia, a company specializing in the shaping of cosmetic products and the manufacture of natural ingredients for cosmetic brands, is selling the majority of his shares in order to develop the company’s shareholding around a team of managers, led by Sébastien Guillotin. Lessonia’s management thus becomes the majority shareholder.

This operation is combined with an entry into the capital of minority investors, NewAlpha Verto, Bpifrance and BNP Paribas Développement, in order to support Lessonia in the new stage of its development.

Jérémie Swiecznik, partner, was involved in this transaction.

Degroux Brugère advised Bpifrance and Kurma Partners, historical investors of Kiro, a company specialized in digital medicine, in its €13.8 million Series A financing round.

The round was led by Sofinnova Partners. The historical investors, the Ambition Amorçage Angels (F3A) fund of France 2030, managed on behalf of the French government by Bpifrance and Kurma Partners, also participated in the financing alongside Propulia Capital, entrepreneurs and European and American business angels.

Thanks to this investment, the Marseille-based start-up is now in a position to develop its artificial intelligence platform for interpreting medical examinations, and also to expand internationally.

This transaction was carried out by DEGROUX BRUGERE with Jérémie Swiecznik, partner.

As part of the development of its high-performance microprocessor, French start-up SiPearl has announced a €90 million Series A financing from ARM, the world leader in semiconductor design, the Atos group (via its Eviden branch), the European Innovation Council (EIC) fund and the French government via the French Tech Souveraineté fund, operated by Bpifrance as part of France 2030. This financing includes up to €25M of convertible debt from the European Investment Bank (EIB).

Launched in 2020, the company is financially supported by the European Commission under the Horizon 2020 program. In 2021, it has been awarded the Accelerator program of the European Innovation Council for a total amount of €17.5M. The deeptech company hopes to raise at least €150 million by the end of the year in order to commercialize its microprocessor in 2024.

Jérémie Swiecznik, partner in the Transactional division, was involved in this transaction.

Entalpic has announced a €8.5 million seed financing round, led by Breega, Cathay Innovation and Felicis, with contributions and advice from Jörg Weiser (ex-Managing Director at Schrödinger), Gilles Wainrib (co-founder of Owkin), Thomas Wolfe (CSO and co-founder of Hugging Face), Arnaud Robert (ex-C-level at Sanofi), Michal Valko (Principal LLama Engineer at Meta, ex-Deepmind) and Yoshua Bengio (Turing Award winner, founder and scientific director of the Mila Institute).

The start-up, a pioneer in generative AI applied to the discovery of materials for the chemical industry accelerated by 21st by CentraleSupélec, is the fruit of a collaboration between researchers at Mila, the world’s leading research laboratory specializing in machine learning for climate action, and a former executive at Owkin, a unicorn renowned for its use of AI applied to drug discovery.
Drawing on this expertise, Entalpic intends to reinvent the discovery of materials and molecules for a more sustainable future.
Jérémie Swiecznik, partner at Degroux Brugère, advised Breega and Cathay Innovation on this transaction.